Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study)

NCT04905511 is registered in ClinicalTrials.gov with Vascudyne, Inc. as lead sponsor.

NCT NCT04905511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04905511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study)
Lead sponsor
Vascudyne, Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 10, 2021
Completion date
June 15, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease